Nelarabine, cyclosphosphamide and etoposide for adults with relapsed T-cell acute lymphoblastic leukaemia and lymphoma
Author:
Affiliation:
1. Abramson Cancer Center and the Division of Hematology and Oncology; Perelman School of Medicine at the University of Pennsylvania; Philadelphia PA USA
2. Department of Pharmacy; Hospital of the University of Pennsylvania; Philadelphia PA USA
Publisher
Wiley
Subject
Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13771/fullpdf
Reference8 articles.
1. Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the Children's Oncology Group;Berg;Journal of Clinical Oncology,2005
2. Salvage therapy with nelarabine, etoposide, and cyclophosphamide in relapsed/refractory paediatric T-cell lymphoblastic leukaemia and lymphoma;Commander;British Journal of Haematology,2010
3. Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801;DeAngelo;Blood,2007
4. Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study;Fielding;Blood,2007
5. How I treat adults with relapsed or refractory Philadelphia chromosome-negative acute lymphoblastic leukemia;Frey;Blood,2015
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Efficacy and prognostic factors of allogeneic hematopoietic stem cell transplantation treatment for adolescent and adult Tlymphoblastic leukemia /lymphoma: a large cohort multicenter study in China;Annals of Hematology;2024-04-06
2. Nelarabine-containing salvage therapy and conditioning regimen in transplants for pediatric T-cell acute lymphoblastic leukemia and lymphoma;International Journal of Hematology;2024-02-01
3. Nelarabine: when and how to use in the treatment of T-cell acute lymphoblastic leukemia;Blood Advances;2023-12-27
4. Integrin signaling is critical for myeloid-mediated support of T-cell acute lymphoblastic leukemia;Nature Communications;2023-10-07
5. Nelarabine combination therapy for relapsed or refractory T-cell acute lymphoblastic lymphoma/leukemia;Blood Advances;2023-03-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3